Accounts & AGM

Interim Report and Financial Statements for the 6 months to 31 December 2022   To download this report as a PDF file click here.

Bioventix plc (“Bioventix” or the “Company”)   Result of AGM Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting held earlier today, all resolutions put to shareholders were [...]

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, confirms that its Annual [...]

Director’s report and financial statements for the year ended 30th June 2022. To download this report as a PDF file click here.

Interim Report and Financial Statements for the 6 months to 31 December 2021   To download this report as a PDF file click here.

Bioventix plc (AIM: BVXP) announces that at its Annual General Meeting (“AGM”), all resolutions put to shareholders were duly passed.

Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, confirms that its Annual [...]

Director’s report and financial statements for the year ended 30th June 2021. To download this report as a PDF file click here

Unaudited interim results for the six months ended 31st December 2020